Share Twitter LinkedIn Facebook Email Damian J. Green, MD, from Seattle Cancer Care Alliance discusses a New Trial CAR T-Cells Targeting BCMA For Multiple Myeloma using Human Anti-BCMA at the 2017 American Society of Hematology.
Teclistamab FDA Approval Biweekly Dosing Multiple Myeloma [3 KOL Interviews] Multiple Myeloma 13 Mins Read